This is the first comprehensive report with a focus on DUB family members in selected pediatric and adult brain tumors, their relationship with ERAD, UPR, DNA damage repair pathways, and their suitability as potential biomarkers and therapeutic targets in defined CNS tumors. This evidence concerns the gene ZUP1 and central nervous system neoplasm.